Pharmaceutical compositions of apremilast
US11266628B2 · kind B2 · utility
0Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 1, 2018 |
| Grant date | Mar 8, 2022 |
| Priority date | — |
| Expiry date | Oct 1, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2853
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a disintegrant free pharmaceutical composition comprising apremilast or pharmaceutically acceptable salts thereof and one or more pharmaceutically acceptable excipients. Particularly the present invention relates to disintegrant free immediate release dosage form comprising apremilast or pharmaceutically acceptable salts thereof and one or more pharmaceutically acceptable excipients. It further relates to process of preparing such composition and its use in psoriatic arthritis and psoriasis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.